Optimizing Outcomes for Patients With Spasticity: Improving Assessment and Maximizing Intervention Options
Wednesday, October 11
8 am-5 pm
Course Directors: Andrea P. Toomer, MD, FAAPMR and Thomas K. Watanabe, MD, FAAPMR
Faculty: Katharine E. Alter, MD, FAAPMR; Franklin S. Domingo, MD; Reza Farid, MD, FAAPMR; John R. McGuire, MD, FAAPMR; Daniel K. Moon, MD, FAAPMR; Michael C. Munin, MD, FAAPMR; Michael F. Saulino, MD, PhD, FAAPMR; Joe Urqidez, MD, FAAPMR
This full-day course is designed for clinicians who may have experience with some of the interventional skills and treatment options related to management of the upper motor neuron syndrome. The course will focus on appropriate assessment and treatment planning, hands-on skills to enhance interventions (including botulinum toxin, nerve blocks and intrathecal baclofen; ultrasound, EMG and electrical stimulation guidance), and information on developing a spasticity management program. Attendees will hear from expert clinicians who will share their technical skills and clinical experiences. Faculty will lead participants through a series of hands-on training to improve technical skills needed to understand all of the treatment options for patients with spasticity.
Upon completion of this course, participants will be able to:
- Discuss the assessment, goal-setting and development an individualized treatment plan for a patient with spasticity.
- Describe the roles of different treatment options for patients with spasticity.
- Identify and utilize anatomical landmarks to aid in electrical stimulation for performing nerve blocks.
- Demonstrate the use of EMG and electrical stimulation to guide focal chemodenervation injections.
- Demonstrate the ability to identify and manage common difficulties associated with intrathecal baclofen pumps.
- Outline a plan to develop a spasticity program.
A Word From Our Course Directors
"Please join us to learn more about helping to improve outcomes for your patients with upper motor neuron syndrome. We’ll discuss appropriate goal-setting and different interventions to consider to achieve those goals. Participants will rotate through 12 different hands-on stations. This will provide an opportunity to develop familiarity with ITB programming and troubleshooting, and to enhance your focal chemodenervation outcomes by developing new localization skills using ultrasound, EMG, and nerve stimulation guidance for botulinum toxin injections and peripheral nerve blocks."— Drs. Toomer and Watanabe
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Academy Tested, Board Approved!
The 2017 Annual Assembly Preconference Courses have been approved by the American Board of Physical Medicine and Rehabilitation (ABPMR) for Maintenance of Certification® (MOC®) Part II Self-Assessment credit. Attendees must complete a post-test to earn AMA PRA Category 1 Credits™, which will be commensurate with the number of CME available for each precourse.
Faculty and topics subject to change.
Support of the education has been provided through educational grants (financial and in-kind). Financial: Allergan, Medtronic, Merz USA, Ipsen Biopharmaceuticals, Inc., and Saol Therapeutics. In-kind durable equipment: GE Healthcare, Edan Medical, Medtronic Konica Minolta, and Blue Phantom. AAPM&R accepts grants in compliance with ACCME Standards for Commercial Support.